Alternatives to liraglutide
FDA shortage status is active for liraglutide; 3 same-class SPL records are listed below for registry comparison only.
Brand: Victoza, Saxenda
liraglutide class peers while FDA lists an active shortage
liraglutide (Victoza, Saxenda) is on an FDA shortage listing while 3 other GLP-1 Receptor Agonist SPL records remain in this registry peer set (class inventory 4). Labeled indication field for liraglutide: Liraglutide helps manage blood sugar levels in people with type 2 diabetes.
Top FAERS reaction fields for liraglutide total 29,079 reports across 10 reactions, set beside dulaglutide, exenatide, semaglutide. Counts are exposure-weighted submissions, not per-patient risk.
About liraglutide
Liraglutide is a medicine that helps lower blood sugar levels. It is used with diet and exercise to treat type 2 diabetes in adults and children 10 years and older.
Used for: Liraglutide helps manage blood sugar levels in people with type 2 diabetes. You should use it along with a healthy diet and regular exercise. It is for adults and children aged 10 and older.
3 GLP-1 Receptor Agonist peers (wide set)
dulaglutide
RxTrulicity
Trulicity helps adults and children 10 years and older manage their type 2 diabetes. It works along with diet and exercise to improve blood sugar control. Trulicity can also reduce the risk of major heart problems like heart attack, stroke, or death in adults with type 2 diabetes who also have heart disease or risk factors for it.
exenatide
RxByetta, Bydureon
Byetta helps adults with type 2 diabetes manage their blood sugar levels. It should be used with a healthy diet and regular exercise. This medicine helps to keep your blood sugar in a normal range.
semaglutide
RxOzempic, Wegovy
Ozempic is used to improve blood sugar control in adults with type 2 diabetes, along with diet and exercise. It can also reduce the risk of major heart problems like heart attack, stroke, or death in adults who have both type 2 diabetes and heart disease. Ozempic has not been studied in patients with a history of pancreatitis, so other diabetes medicines may be better for you.
liraglutide vs dulaglutide & exenatide · FAERS reaction fields
FAERS top-reaction field "Blood Glucose Increased" shows the widest count spread between liraglutide and dulaglutide, exenatide, semaglutide in this extract (11,597-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.
| Side Effect | liraglutide | dulaglutide | exenatide | semaglutide |
|---|---|---|---|---|
| Nausea | 7,005 | 9,986 | 12,040 | 10,666 |
| Blood Glucose Increased | 3,875 | 9,762 | 15,472 | 2,752 |
| Vomiting | 3,364 | 5,413 | 4,345 | 6,913 |
| Diarrhoea | 3,263 | 5,737 | 2,742 | 6,093 |
| Pancreatitis | 2,315 | - | 2,012 | - |
| Weight Decreased | 2,076 | 3,349 | 12,125 | 3,931 |
| Decreased Appetite | 2,066 | 3,153 | 5,643 | 4,428 |
| Headache | 1,988 | - | 2,086 | 3,156 |
"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.
liraglutide shortage vs GLP-1 Receptor Agonist peer index
Shortage status
FDA shortage listing is active for liraglutide (status: Current). Peer rows remain a registry index, not a switch guide.
Frequently Asked Questions
Does FDA list a shortage for liraglutide while peers remain indexed? ▼
Registry note: Shortage listings and peer indexes are for registry orientation only. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for liraglutide: see also the generic vs brand label guide when reading Victoza SPL strings.
Read our methodology - how this data is sourced, computed, and verified.